Search for a rare disease
Other search option(s)
Acquired methemoglobinemia
Disease definition
A rare hematologic disease characterized by increased levels of methemoglobin in the blood due to exposure to oxidizing agents like nitrates or nitrites, a variety of medications (most commonly local anesthetics), or aniline dyes, among others. Clinical manifestations include cyanosis, dizziness, headache, dyspnea, confusion, and coma. The severity of symptoms ranges from mild to life-threatening, depending on the percentage of methemoglobin.
ORPHA:464453
Classification level: Disorder- Synonym(s):
- Drug-induced methemoglobinemia
- Prevalence: Unknown
- Inheritance: Not applicable
- Age of onset: All ages
- ICD-10: D74.8
- ICD-11: 3A93
- OMIM: -
- UMLS: C0271905
- MeSH: -
- GARD: -
- MedDRA: -
A summary on this disease is available in Deutsch (2020) Español (2020) Français (2020) Nederlands (2020)
Detailed information
Guidelines
- Clinical practice guidelines
- English (2010) - Br J Haematol
- English (2015) - Eur J Hum Genet
- English (2021) - Am J Hematol


Additional information
Further information on this disease
Patient-centred resources for this disease
Research activities on this disease
Specialised Social Services
The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.